EPAS1 Antikörper (N-Term)
Kurzübersicht für EPAS1 Antikörper (N-Term) (ABIN2260411)
Target
Alle EPAS1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 127-154, N-Term
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- EPAS1, NT (EPAS1, BHLHE73, HIF2A, MOP2, PASD2, Endothelial PAS domain-containing protein 1, Basic-helix-loop-helix-PAS protein MOP2, Class E basic helix-loop-helix protein 73, HIF-1-alpha-like factor, Hypoxia-inducible factor 2-alpha, Member of PAS protein 2, PAS domain-containing protein 2)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- EPAS1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 127-154 amino acids from the N-terminal region of human EPAS1.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- EPAS1 (Endothelial PAS Domain Protein 1 (EPAS1))
-
Andere Bezeichnung
- EPAS1
-
NCBI Accession
- NP_001421
-
UniProt
- Q99814
-
Pathways
- Signaling Events mediated by VEGFR1 and VEGFR2, Warburg Effekt
Target
-